Drug Discovery World (DDW), the Quarterly Business Review of Drug Discovery & Development

DDW Article Database

LATEST ISSUE: WINTER 2017/18

ARTIFICIAL INTELLIGENCE and biopharma R&D IT

By The PRISME Forum

"R&D productivity remains an ongoing concern. Artificial Intelligence and the accompanying analytics are now so advanced that these tools promise t...

Bringing IO together: how an immunologist and oncologist collaborate

By Dr Julia Schuler and Dr Louise Brackenbury

For many years, immunology and oncology operated as separate disciplines within drug discovery. However, recent advances in immuno-oncology (IO) ha...

The Cancer Conundrum increasing clinical success

By Lubna Hussain

Increasing clinical success by implementing improved methodologies in early phase drug discovery. Using primary cells and 3D culture models to enha...

Driving strategic improvements in biologics drug discovery with scientific informatics

By Dr Andrew LeBeau

Adoption of a scientific informatics system is essential to the success of every drug discovery organisation.

KINASES - old dogs and new tricks

By Dr Gary Allenby

Application of new assay technologies to shed light on kinase drug discovery.

Disruptive approaches to accelerate drug discovery and development

By Ibis Sanchez- Serrano, Dr Tom Pfeifer and Dr Rathnam Chaguturu

This article is part 1 of 2, and covers tools, technologies and the core model.

How high-throughput CRISPR is set to deliver knockout performance in drug discovery

By Dr Paul Avery and Dr Richard Massey

CRISPR-Cas9 has rapidly transformed our ability to perform targeted gene editing. While the technique has received much interest for its potential ...